The immunofluorescence quantification results revealed a significant decrease in the expression levels (fluorescence intensity) of neovascularization marker CD31 in the DET- and DETD-35-treated groups compared to the tumor control, supporting the above observation that both compounds block tumor angiogenesis in metastatic lung tissues (Figure 7F). Here, PECAM1 is linked to neoplasm.